OR9P1P

Across TCGA pan-cancer cohorts, OR9P1P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated OR9P1P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher OR9P1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR9P1P expression acts as an unfavorable survival marker.

COAD, BLCA, and ESCA are the cancer types where OR9P1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	II,III,IV	0.039	0.851	<.001	90	view →
BLCA	OS	Tertile	IV	0.105	0.605	<.001	45	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
UCEC	OS	Tertile	All	0.835	0.928	.008	36	view →
OV	DFS	Tertile	All	0.452	0.551	.022	36	view →
BRCA	OS	Tertile	II,III,IV	0.900	0.960	.020	15	view →
SKCM	DFS	Tertile	II,III,IV	0.277	0.596	.024	12	view →
SARC	DFS	Tertile	All	0.181	0.597	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

OR9P1P–COAD (OS)

Open the COAD breakdown →